TSX · AVNT.TO
Avant Brands Inc.
CA$0.52+CA$0.03 (+5.05%)
Avant Brands Inc.’s quoted price sits in the lower half of its reported 52-week range, 51.4% below the high.
Loading market information…
CNQ · MVMD.CN · CAD
Stock price, earnings
Quote as of Aug 19, 2026, 06:14 PM UTC. Cached market data; not a live quote.
One-year closing-price history · CAD. Historical prices are not a forecast.
Mountain Valley MD Holdings Inc.’s quoted price sits in the upper half of its reported 52-week range, 33.33% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Mountain Valley MD Holdings Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Mountain Valley MD Holdings Inc., operating through its subsidiary Mountain Valley MD Inc., functions as a health and wellness enterprise. The company focuses on deploying and licensing its proprietary innovations to external entities within the pharmaceutical, vaccine, and nutritional supplement sectors. Its portfolio encompasses Quicksome, an advanced technology for oral drug formulation and delivery; Quicksol, designed for enhancing solubility; and a dose-sparing adjuvant. Additionally, the firm is actively developing IM032, a compound currently being evaluated in male beagle dogs to assess intramuscular versus subcutaneous administration methods. Mountain Valley MD Holdings Inc. is headquartered in Concord, Canada.
Latest available per-share figures in CAD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 12:12 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CA$0.52+CA$0.03 (+5.05%)
Avant Brands Inc.’s quoted price sits in the lower half of its reported 52-week range, 51.4% below the high.
CA$0.04CA$0.00 (0.0%)
Kane Biotech Inc.’s quoted price sits in the upper half of its reported 52-week range, 30.0% below the high.
CA$0.02-CA$0.01 (-25.0%)
Revive Therapeutics Ltd.’s quoted price sits in the lower half of its reported 52-week range, 81.25% below the high.
CA$0.05+CA$0.01 (+11.11%)
Avricore Health Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
CA$2.40CA$0.00 (0.0%)
Aptose Biosciences Inc.’s quoted price sits in the upper half of its reported 52-week range, 3.23% below the high.
CA$0.11+CA$0.01 (+10.0%)
Mercanto Holdings Inc.’s quoted price sits in the lower half of its reported 52-week range, 35.29% below the high.
CA$0.01CA$0.00 (0.0%)
1933 Industries Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
CA$0.05CA$0.00 (0.0%)
Telo Genomics Corp.’s quoted price sits in the lower half of its reported 52-week range, 52.38% below the high.
